{
    "clinical_study": {
        "@rank": "25186", 
        "arm_group": [
            {
                "arm_group_label": "rs2242480 wild-type homozygote", 
                "description": "*1/*1 Grouped by rs2242480 polymorphism genotyping"
            }, 
            {
                "arm_group_label": "rs2242480 mutant heterozygote", 
                "description": "*1/*1G Grouped by rs2242480 polymorphism genotyping"
            }, 
            {
                "arm_group_label": "rs2242480 mutant homozygote", 
                "description": "*1G/*1G Grouped by rs2242480 polymorphism genotyping"
            }
        ], 
        "biospec_descr": {
            "textblock": "The blood samples were drawn before anesthesia\uff0c30 min and 45min after anesthesia\n      respectively\uff0cused for genotyping and plasma sufentanil concentration detection with high\n      performance liquid chromatography-mass spectrometry (HPLC-MS)."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This study was designed for exploring the association of cytochrome P450 3A4 rs2242480\n      polymorphism with metabolism of sufentanil in Chinese patients receiving upper abdominal\n      surgery\uff0cto provide evidence for genetic prediction of personalized medication.Methods:60\n      patients who prepared for elective upper abdominal surgery under general anesthesia were\n      recruited into study. Liver enzyme inhibitor should be excluded in anesthesia. rs2242480\n      genotyping was carried out by direct sequencing. The blood samples were drawn before\n      anesthesia\uff0c30 min and 45min after anesthesia respectively\uff0cused for  plasma sufentanil\n      concentration detection with high performance liquid chromatography-mass spectrometry\n      (HPLC-MS). After surgery\uff0cthe patients received patient-controlled intravenous sufentanil\n      immediately. And postoperative pain at rest\uff0csufentanil consumption\uff0cside effects and rescue\n      analgesic requirements were recorded at the 6th\uff0c12th\uff0c24th hour. The plasma sufentanil\n      concentration and PCA sufentanil consumption were analyzed to investigate the differences\n      among rs2242480 three genotypes."
        }, 
        "brief_title": "Association of CYP3A4 rs2242480 With Sufentanil Plasma Concentration and PCA Consumption", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Surgery", 
            "Individuality"
        ], 
        "detailed_description": {
            "textblock": "The study consisted of healthy men and women between 18 to 65 years of age.\n\n      Participants were screened and stratified according to cytochrome P450 3A4 rs2242480\n      genotype:\n\n        -  1/*1 Grouped by rs2242480 polymorphism, wild-type homozygote\n\n        -  1/*1G Grouped by rs2242480 polymorphism,*1/*1G: mutant heterozygote\n\n        -  1G/*1G Grouped by rs2242480 polymorphism,*1G/*1G: mutant homozygote"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1.American Society of Anesthesiologists (ASA) physical status I or II 2.age from 18\n             to 65 years old 3.BMI of 19\uff5e26kg/m2\n\n        Exclusion Criteria:\n\n          -  1.known history of chronic pain, psychiatric diseases, diabetes mellitus, severe\n             cardiovascular diseases, kidney or liver diseases with poor hepatic function\n             2.alcohol or drug abuse (according to the criteria of Diagnostic and Statistical\n             Manual of Mental Disorders-IV) 3.pregnancy or at lactation period 4.Patients who\n             consumed drugs (1 week) or foods (3 days) known to inhibit or induce the expression\n             of cytochrome P450 3A4 enzymes prior to surgery were also excluded. The following\n             drugs or foods included but were not limited to erythromycin, clarithromycin,\n             alcohol, chocolate, coffee, grapefruit juice, verapamil, rifampicin, HIV protease\n             inhibitors, phenytoin,itraconazole, dexamethasone, phenobarbital, and carbamazepine."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "60 Chinese male and female patients receiving elective upper abdominal surgery (liver,\n        pancreatic, gallbladder) under general anesthesia"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070614", 
            "org_study_id": "CYP3A4 and sufentanil"
        }, 
        "intervention_browse": {
            "mesh_term": "Sufentanil"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "sufentanil", 
            "metabolism", 
            "cytochrome P450 3A4", 
            "gene polymorphism"
        ], 
        "lastchanged_date": "February 23, 2014", 
        "location": {
            "contact": {
                "email": "zhangcaie1972@126.com", 
                "last_name": "Caie Zhang, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Wuhan", 
                    "country": "China", 
                    "state": "Hubei", 
                    "zip": "430030"
                }, 
                "name": "Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "3", 
        "official_title": "Association of CYP3A4 rs2242480 With Sufentanil Plasma Concentration and PCA Consumption", 
        "overall_contact": {
            "email": "znpain@sina.com", 
            "last_name": "Xianwei Zhang, MD", 
            "phone": "13037154560"
        }, 
        "overall_official": {
            "affiliation": "Huazhong University of Science and Technology", 
            "last_name": "Xianwei Zhang, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "according to rs2242480 genotype and plasma concentration of sufentanil", 
            "measure": "the correlation between rs2242480 polymorphism and sufentanil metabolism", 
            "safety_issue": "Yes", 
            "time_frame": "4 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070614"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Huazhong University of Science and Technology", 
            "investigator_full_name": "Xianwei Zhang", 
            "investigator_title": "Clinical Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "the single-dose sufentanil plasma concentration varies between participants, and the differences among 3 time-points is related with personal genotype.", 
                "measure": "Variation of plasma concentration of sufentanil", 
                "safety_issue": "Yes", 
                "time_frame": "4 months"
            }, 
            {
                "description": "according to postoperative PCA sufentanil consumption and rs2242480 genotype", 
                "measure": "relation between rs2242480 genotype and patient-controlled analgesia(PCA) consumption of sufentanil", 
                "safety_issue": "Yes", 
                "time_frame": "4 months"
            }, 
            {
                "description": "according to PCA VAS and rs2242480 genotype", 
                "measure": "relation between Visual Analogue Scale/Score(VAS) and rs2242480", 
                "safety_issue": "Yes", 
                "time_frame": "4 months"
            }
        ], 
        "source": "Huazhong University of Science and Technology", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Xianwei Zhang", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}